Pulmonx Corporation

NASDAQ: LUNG · Real-Time Price · USD
1.60
0.04 (2.56%)
At close: Aug 18, 2025, 3:59 PM
1.62
1.25%
Pre-market: Aug 19, 2025, 04:11 AM EDT

Pulmonx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
23.86M 22.54M 23.77M 20.39M 20.78M 18.85M 19.28M 17.67M 17.19M 14.54M 15.43M 13.5M 13.95M 10.79M 13.71M 13.26M 12.2M 9.24M
Cost of Revenue
6.66M 6.2M 6.08M 5.36M 5.48M 4.88M 4.98M 4.64M 4.46M 3.95M 4.24M 3.35M 3.53M 2.67M 3.46M 3.52M 3.17M 2.63M
Gross Profit
17.2M 16.34M 17.69M 15.03M 15.31M 13.98M 14.3M 13.03M 12.73M 10.59M 11.18M 10.15M 10.42M 8.11M 10.25M 9.74M 9.03M 6.61M
Operating Income
-14.8M -14.56M -15.13M -14.13M -13.9M -14.54M -13.92M -15.18M -16.44M -16.4M -14.63M -13.93M -14.41M -15.67M -12.37M -9.76M -12.1M -12.03M
Interest Income
723K 864K 1.04M 1.27M 1.31M 1.44M 1.54M 1.49M 1.41M 1.13M 748K 477K 199K 105K 94K 99K 102K 105K
Pretax Income
-15M -14.31M -13.14M -13.95M -15.24M -13.56M -13.64M -14.84M -16.05M -15.74M -14.04M -14.17M -14.6M -15.76M -12.85M -10.14M -12.3M -11.98M
Net Income
-15.17M -14.45M -13.18M -14.14M -15.33M -13.75M -13.89M -14.9M -16.2M -15.86M -14.28M -13.79M -14.64M -15.83M -13.01M -10.18M -12.38M -12.04M
Selling & General & Admin
26.7M 26.15M 27.11M 25.41M 25.31M 24.3M 24.32M 23.98M 23.46M 22.74M 21.91M 19.72M 21.23M 20.25M 18.91M 16.69M 17.62M 15.6M
Research & Development
5.31M 4.76M 5.72M 3.74M 3.9M 4.21M 3.9M 4.22M 5.71M 4.25M 3.9M 4.37M 3.59M 3.53M 3.71M 2.81M 3.51M 3.03M
Other Expenses
n/a n/a n/a n/a -35K n/a n/a -262K -162K 108K 201K n/a -165K n/a n/a n/a -96K 161K
Operating Expenses
32.01M 30.91M 32.82M 29.16M 29.21M 28.51M 28.22M 28.2M 29.17M 26.99M 25.81M 24.08M 24.83M 23.78M 22.62M 19.5M 21.13M 18.64M
Interest Expense
-2.36M 781K 842K 891K 891K 883K 905K 893K 864K 571K 359K 286K 223K 198K 199K 207K 206K 217K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 4.8M n/a n/a n/a 6.1M n/a n/a n/a 5.1M n/a n/a n/a
Cost & Expenses
38.66M 37.1M 38.9M 34.52M 34.69M 33.39M 33.2M 32.84M 33.63M 30.93M 30.05M 27.43M 28.36M 26.45M 26.07M 23.02M 24.3M 21.27M
Income Tax Expense
177K 135K 38K 192K 84K 186K 248K 59K 140K 124K 246K -383K 40K 67K 152K 44K 80K 67K
Shares Outstanding (Basic)
40.19M 39.95M 39.11M 39.28M 38.94M 38.64M 38.38M 38.12M 37.82M 37.57M 37.38M 37.19M 37M 36.81M 36.64M 36.45M 36.04M 35.37M
Shares Outstanding (Diluted)
40.19M 39.95M 39.11M 39.28M 38.94M 38.64M 38.38M 38.12M 37.82M 37.57M 37.38M 37.19M 37M 36.81M 36.64M 36.45M 36.04M 35.37M
EPS (Basic)
-0.38 -0.36 -0.33 -0.36 -0.39 -0.36 -0.36 -0.39 -0.43 -0.42 -0.38 -0.37 -0.4 -0.43 -0.35 -0.28 -0.34 -0.34
EPS (Diluted)
-0.38 -0.36 -0.33 -0.36 -0.39 -0.36 -0.36 -0.39 -0.43 -0.42 -0.38 -0.37 -0.4 -0.43 -0.35 -0.28 -0.34 -0.34
EBITDA
-17.89M -14.56M -18.91M -12.69M -13.95M -12.16M -12.35M -13.53M -14.11M -14.07M -12.77M -13.5M -14M -15.2M -11.76M -9.72M -12.1M -12.03M
EBIT
-14.2M -15.09M -19.31M -13.06M -14.35M -12.68M -12.73M -13.95M -15.19M -15.16M -13.68M -13.89M -14.38M -15.56M -12.65M -9.93M -12.68M -12.23M
Depreciation & Amortization
-531K 531K 194K 376K 400K 523K 387K 415K 1.08M 1.09M 912K 1.02M 988K 982K 894K 917K 777K 772K